Literature DB >> 26679472

TLR2 Regulates Complement-Mediated Inflammation Induced by Blood Loss During Hemorrhage.

Jeremy Goering1, Michael R Pope, Sherry D Fleming.   

Abstract

Hemorrhagic shock resulting from blood loss directs the majority of the blood to the vital organs, dramatically reducing blood flow to the intestines and resulting in damage and inflammation. The excessive intestinal inflammatory response includes pro-inflammatory cytokines and complement activation, although the mechanism is not clear. Toll-like receptors play a vital role in the innate immune response and toll-like receptor 2 (TLR2) is required for intestinal ischemia/reperfusion-induced injury. We hypothesized that TLR2 plays an integral role in the intestinal inflammatory response after hemorrhage and subjected C57Bl/6 wild-type and Tlr2(-/-) mice to atraumatic loss of ∼30% total blood volume. Two hours after blood removal, the intestinal injury and inflammation were assessed. We demonstrate that compared with wild-type control mice, Tlr2(-/-) mice sustain less intestinal damage and inflammation. Importantly, TLR2 regulated eicosanoid and complement activation and IL-12 and TNFα secretions, indicating interactions between TLR2 and complement in response to significant blood loss.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26679472      PMCID: PMC4685733          DOI: 10.1097/SHK.0000000000000477

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  38 in total

1.  Complement activation mediates intestinal injury after resuscitation from hemorrhagic shock.

Authors:  D A Spain; T M Fruchterman; P J Matheson; M A Wilson; A W Martin; R N Garrison
Journal:  J Trauma       Date:  1999-02

2.  Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation.

Authors:  Jie Fan; Yuehua Li; Yoram Vodovotz; Timothy R Billiar; Mark A Wilson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-11-04       Impact factor: 5.464

3.  Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells.

Authors:  Roop Gill; Xiangcai Ruan; Christoph L Menzel; Seung Namkoong; Patricia Loughran; David J Hackam; Timothy R Billiar
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

Review 4.  General principles of small animal blood component administration.

Authors:  A T Kristensen; B F Feldman
Journal:  Vet Clin North Am Small Anim Pract       Date:  1995-11       Impact factor: 2.093

5.  Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury.

Authors:  Conrad A Farrar; Brian Keogh; William McCormack; Aisling O'Shaughnessy; Andrew Parker; Mary Reilly; Steven H Sacks
Journal:  FASEB J       Date:  2011-10-31       Impact factor: 5.191

6.  TLR2 signaling subpathways regulate TLR9 signaling for the effective induction of IL-12 upon stimulation by heat-killed Brucella abortus.

Authors:  Chun-Yan Zhang; Nan Bai; Zhu-Hong Zhang; Ning Liang; Lan Dong; Rong Xiang; Cheng-Hu Liu
Journal:  Cell Mol Immunol       Date:  2012-05-28       Impact factor: 11.530

7.  Microbial hijacking of complement-toll-like receptor crosstalk.

Authors:  Min Wang; Jennifer L Krauss; Hisanori Domon; Kavita B Hosur; Shuang Liang; Paola Magotti; Martha Triantafilou; Kathy Triantafilou; John D Lambris; George Hajishengallis
Journal:  Sci Signal       Date:  2010-02-16       Impact factor: 8.192

8.  Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.

Authors:  Julie Favre; Philippe Musette; Victorine Douin-Echinard; Karine Laude; Jean-Paul Henry; Jean-François Arnal; Christian Thuillez; Vincent Richard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-03-01       Impact factor: 8.311

9.  TLR Cross-Talk Mechanism of Hemorrhagic Shock-Primed Pulmonary Neutrophil Infiltration.

Authors:  Jie Fan
Journal:  Open Crit Care Med J       Date:  2010-01-01

10.  A novel TLR2-triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 induction.

Authors:  Yu-Ling Chang; Tzu-Hui Chen; Yi-Hsiu Wu; Guann-An Chen; Tzu-Huei Weng; Ping-Hui Tseng; Shie-Liang Hsieh; Shu-Ling Fu; Chi-Hung Lin; Chun-Jen Chen; Ching-Liang Chu; Iok In Christine Chio; Tak Wah Mak; Nien-Jung Chen
Journal:  J Cell Mol Med       Date:  2014-04-24       Impact factor: 5.310

View more
  4 in total

1.  Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic Shock.

Authors:  Martijn van Griensven; Daniel Ricklin; Stephanie Denk; Rebecca Halbgebauer; Christian K Braun; Anke Schultze; Felix Hönes; Sofia Koutsogiannaki; Alexandra Primikyri; Edimara Reis; David Messerer; Sebastian Hafner; Peter Radermacher; Ali-Reza Biglarnia; Ranillo R G Resuello; Joel V Tuplano; Benjamin Mayer; Kristina Nilsson; Bo Nilsson; John D Lambris; Markus Huber-Lang
Journal:  Shock       Date:  2019-01       Impact factor: 3.454

2.  Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [18F]F-FDG PET-CT in a Mouse Model of Cardiac Arrest and Cardiopulmonary Resuscitation.

Authors:  Rika Bajorat; Jens Kurth; Jan Stenzel; Brigitte Vollmar; Bernd J Krause; Daniel A Reuter; Tobias Schuerholz; Stefan Bergt
Journal:  Mol Imaging Biol       Date:  2021-11-15       Impact factor: 3.484

3.  Lactobacillus murinus alleviate intestinal ischemia/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling.

Authors:  Jingjuan Hu; Fan Deng; Bingcheng Zhao; Zebin Lin; Qishun Sun; Xiao Yang; Mei Wu; Shida Qiu; Yu Chen; Zhengzheng Yan; Sidan Luo; Jin Zhao; Weifeng Liu; Cai Li; Ke Xuan Liu
Journal:  Microbiome       Date:  2022-03-03       Impact factor: 14.650

Review 4.  Innate immunity and immunotherapy for hemorrhagic shock.

Authors:  Qingxia Huang; Song Gao; Yao Yao; Yisa Wang; Jing Li; Jinjin Chen; Chen Guo; Daqing Zhao; Xiangyan Li
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.